Processa Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Issued from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Processa Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q2 2024.
  • Processa Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 2.87M shares, a 88.3% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 2.87M -21.8M -88.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 2.86M -21.8M -88.4% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 1.29M +484K +60% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 24.7M +8.74M +54.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 24.6M +8.71M +54.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 24.6M +8.69M +54.6% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 807K -14.9M -94.9% Dec 31, 2022 10-K 2024-03-29
Q3 2022 16M +396K +2.54% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 15.9M +315K +2.02% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 15.9M +416K +2.68% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 15.7M +1.53M +10.8% Dec 31, 2021 10-K 2023-03-30
Q3 2021 15.6M +9.83M +171% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 15.6M +10.1M +183% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 15.5M +10M +183% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 14.2M +8.7M +158% Dec 31, 2020 10-K 2022-03-30
Q3 2020 5.77M -32.6M -85% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 5.51M -33.2M -85.7% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 5.49M -33.2M -85.8% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 5.49M -38.4K -0.7% Dec 31, 2019 10-K 2021-03-25
Q3 2019 38.4M -270K -0.7% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 38.7M 0 0% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 38.7M +3.4M +9.64% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 5.53M -29.7M -84.3% Dec 31, 2018 10-K 2020-03-06
Q3 2018 38.7M +14M +56.6% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 38.7M +27.7M +251% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 35.3M +24.3M +220% Mar 31, 2018 10-Q 2018-05-21
Q4 2017 35.3M +3.53M +11.1% Dec 31, 2017 10-K/A 2019-04-08
Q3 2017 24.7M +13.7M +124% Sep 30, 2017 10-Q 2017-11-20
Q2 2017 11M 0 0% Jun 30, 2017 10-Q 2017-10-04
Q1 2017 11M 0 0% Mar 31, 2017 10-Q 2017-10-04
Q4 2016 31.7M +20.7M +188% Dec 31, 2016 10-K 2018-04-16
Q3 2016 11M -44K -0.4% Sep 30, 2016 10-Q 2017-09-08
Q2 2016 11M -43.7K -0.4% Jun 30, 2016 10-Q 2017-08-30
Q1 2016 11M -43.7K -0.4% Mar 31, 2016 10-Q 2017-08-07
Q4 2015 11M +1.52M +16% Dec 31, 2015 10-K 2017-09-25
Q3 2015 11.1M +2.77M +33.5% Sep 30, 2015 10-Q 2015-12-01
Q2 2015 11.1M +2.63M +31.2% Jun 30, 2015 10-Q 2015-08-19
Q1 2015 11.1M +2.79M +33.7% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 9.5M +1.41M +17.5% Dec 31, 2014 10-K 2017-06-19
Q3 2014 8.29M +241K +2.99% Sep 30, 2014 10-Q 2014-11-13
Q2 2014 8.43M +1.4M +19.9% Jun 30, 2014 10-Q 2014-08-19
Q1 2014 8.27M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 8.08M +6.18M +325% Dec 31, 2013 10-K 2015-04-14
Q3 2013 8.05M Sep 30, 2013 10-Q 2013-11-08
Q2 2013 7.03M Jun 30, 2013 10-Q/A 2013-09-06
Q4 2012 1.9M Dec 31, 2012 10-K 2014-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.